Literature DB >> 17610341

Cost-utility analysis in China: differences and difficulties compared with developed countries.

Liu Bao Peng, Chong Qing Tan, Xiao Min Wan, Wei Cui.   

Abstract

Mesh：

Year:  2007        PMID： 17610341     DOI： 10.2165/00019053-200725070-00007

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  3 in total

1.  A cost-utility analysis of hysterectomy, endometrial resection and ablation and medical therapy for menorrhagia.

Authors:  Joyce H S You; Daljit Singh Sahota; Pong MoYuen
Journal:  Hum Reprod       Date:  2006-04-03       Impact factor: 6.918

2.  [Combined high dose leucovorin and 5-fluorouracil continuous infusion for head-neck and digestive tract cancers].

Authors:  Deming Xu; Guoquan Chen; Shengyi Li; Yongguang Cai; Huanwei Chen; Huahai Ling; Ziqing Li
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2002-01

3.  Cost-utility analysis for endoscopic sinus surgery.

Authors:  Pa-Chun Wang; Chia-Chen Chu; Shu-Cheng Liang; Chih-Jaan Tai
Journal:  Otolaryngol Head Neck Surg       Date:  2004-01       Impact factor: 3.497
  3 in total
  3 in total

1.  Health-related quality of life in Chinese patients with chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Fei-Li Zhao; Ming Yue; Hua Yang; Tian Wang; Jiu-Hong Wu; Shu-Chuen Li
Journal:  Qual Life Res       Date:  2010-06-24       Impact factor: 4.147

2.  Cost-effectiveness analysis of adjuvant therapy for operable breast cancer from a Chinese perspective: doxorubicin plus cyclophosphamide versus docetaxel plus cyclophosphamide.

Authors:  Peng Liubao; Wan Xiaomin; Tan Chongqing; Jon Karnon; Chen Gannong; Li Jianhe; Cui Wei; Luo Xia; Cao Junhua
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 3.  Clinical utility and patient consideration in the use of lenalidomide for multiple myeloma in Chinese patients.

Authors:  Jing Wang; Hongfeng Guo; Xin Zhou
Journal:  Onco Targets Ther       Date:  2015-06-02       Impact factor: 4.147
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.